Status:
RECRUITING
Esophageal Cancer Risk Registry
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Conditions:
Esophageal Cancer
Gastroesophageal Reflux Disease (GERD)
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to identify markers in the blood and tissue that could indicate risk factors for the development and progression of esophagus cancer. This research aims to collect medical...
Detailed Description
We will enroll patients with esophageal cancer, patients who are at risk for developing esophageal cancer, and patients who have a non-cancerous esophageal disorder. All patients will be asked to fill...
Eligibility Criteria
Inclusion
- Known or suspected esophageal or gastroesophageal junction malignancy
- Known Barrett's metaplasia
- Clinical management of symptomatic gastroesophageal reflux disease (GERD)
- Achalasia
- Hiatal hernia
Exclusion
- Elevated pre-operative bloodwork will not have the additional biopsies taken.
- Platelet count less than 150,000, partial thromboplastin time (PTT) of 50 or above, and/or International Normalized Ratio (INR) of 1.8 or above will not have the additional biopsies taken.
Key Trial Info
Start Date :
June 1 1999
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2050
Estimated Enrollment :
7000 Patients enrolled
Trial Details
Trial ID
NCT00260585
Start Date
June 1 1999
End Date
December 1 2050
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiothoracic Surgery
Pittsburgh, Pennsylvania, United States, 15232